An immunomodulatory drug called fingolimod, which is approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and transmission in human immune cells, according to a study published ...
Aug 13, 2020
0
47
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania ...
Aug 10, 2020
0
2
A newly discovered mechanism at work in human immunodeficiency virus (HIV) patients may also lead to new treatments for COVID-19, according to a team of researchers at the University of Alberta.
Jul 31, 2020
0
928
Researchers have developed a way to pull HIV out of the latent reservoir making the virus visible to the immune system and providing the potential to be killed by treatment.
Jul 9, 2020
0
57
Scientists are reporting an early step toward an HIV drug that could potentially be taken only a couple of times per year.
Jul 1, 2020
0
107
Yale researchers have identified four drugs that may help minimize the long-term health effects of HIV infection, they report June 23 in the Journal of Clinical Investigation.
Jun 23, 2020
0
1
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in ...
May 13, 2020
0
126
A regulatory conundrum faces researchers trying to slow the spread of HIV among minors. Sometimes those researchers need consent from parents, a requirement that can leave some of the most endangered minors out of the picture.
May 4, 2020
0
3
New research on the structure of the human immunodeficiency virus (HIV) has revealed a promising novel drug target for treating HIV infection, which affects more than 1 million Americans and 40 million people worldwide. The ...
Apr 23, 2020
0
211
"Am I going to die?"
Apr 16, 2020
0
2
